NCT00091910View on ClinicalTrials.gov

Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,460

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

June 30, 2006

Conditions

Anemia

Interventions

DRUG

Epoetin alfa

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00091910 - Research Into the Treatment of Anemia for Critically Ill Patients Admitted to Intensive Care Units (ICU) | Biotech Hunter | Biotech Hunter